891 related articles for article (PubMed ID: 18242867)
1. Application of in vitro anthelmintic sensitivity assays to canine parasitology: detecting resistance to pyrantel in Ancylostoma caninum.
Kopp SR; Coleman GT; McCarthy JS; Kotze AC
Vet Parasitol; 2008 Apr; 152(3-4):284-93. PubMed ID: 18242867
[TBL] [Abstract][Full Text] [Related]
2. High-level pyrantel resistance in the hookworm Ancylostoma caninum.
Kopp SR; Kotze AC; McCarthy JS; Coleman GT
Vet Parasitol; 2007 Feb; 143(3-4):299-304. PubMed ID: 17011128
[TBL] [Abstract][Full Text] [Related]
3. Acetylcholine receptor subunit genes from Ancylostoma caninum: altered transcription patterns associated with pyrantel resistance.
Kopp SR; Coleman GT; Traub RJ; McCarthy JS; Kotze AC
Int J Parasitol; 2009 Mar; 39(4):435-41. PubMed ID: 18823982
[TBL] [Abstract][Full Text] [Related]
4. Multiple drug resistance in the canine hookworm Ancylostoma caninum: an emerging threat?
Jimenez Castro PD; Howell SB; Schaefer JJ; Avramenko RW; Gilleard JS; Kaplan RM
Parasit Vectors; 2019 Dec; 12(1):576. PubMed ID: 31818311
[TBL] [Abstract][Full Text] [Related]
5. Anthelmintic activity of closantel against Ancylostoma caninum in dogs.
Guerrero J; Page MR; Schad GA
J Parasitol; 1982 Aug; 68(4):616-9. PubMed ID: 7119989
[TBL] [Abstract][Full Text] [Related]
6. Field evaluation of anthelmintic drug sensitivity using in vitro egg hatch and larval motility assays with Necator americanus recovered from human clinical isolates.
Kotze AC; Coleman GT; Mai A; McCarthy JS
Int J Parasitol; 2005 Apr; 35(4):445-53. PubMed ID: 15777920
[TBL] [Abstract][Full Text] [Related]
7. Dose-response assay templates for in vitro assessment of resistance to benzimidazole and nicotinic acetylcholine receptor agonist drugs in human hookworms.
Kotze AC; Lowe A; O'Grady J; Kopp SR; Behnke JM
Am J Trop Med Hyg; 2009 Jul; 81(1):163-70. PubMed ID: 19556583
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of an ivermectin/pyrantel pamoate chewable formulation against the canine hookworms, Uncinaria stenocephala and Ancylostoma caninum.
Nolan TJ; Hawdon JM; Longhofer SL; Daurio CP; Schad GA
Vet Parasitol; 1992 Feb; 41(1-2):121-5. PubMed ID: 1532872
[TBL] [Abstract][Full Text] [Related]
9. Efficacy evaluation of anthelmintic products against an infection with the canine hookworm (Ancylostoma caninum) isolate Worthy 4.1F3P in dogs.
Jimenez Castro PD; Mansour A; Charles S; Hostetler J; Settje T; Kulke D; Kaplan RM
Int J Parasitol Drugs Drug Resist; 2020 Aug; 13():22-27. PubMed ID: 32403053
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic characterization of two Ancylostoma caninum isolates with different susceptibilities to the anthelmintic pyrantel.
Kopp SR; Coleman GT; McCarthy JS; Kotze AC
Antimicrob Agents Chemother; 2008 Nov; 52(11):3980-6. PubMed ID: 18710918
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of milbemycin oxime against experimentally induced Ancylostoma caninum and Uncinaria stenocephala infections in dogs.
Niamatali S; Bhopale V; Schad GA
J Am Vet Med Assoc; 1992 Nov; 201(9):1385-7. PubMed ID: 1429184
[TBL] [Abstract][Full Text] [Related]
12. Anthelmintic activity of cyclotides: In vitro studies with canine and human hookworms.
Colgrave ML; Kotze AC; Kopp S; McCarthy JS; Coleman GT; Craik DJ
Acta Trop; 2009 Feb; 109(2):163-6. PubMed ID: 19059189
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio
Snyder DE; Wiseman S; Crawley E; Wallace K; Bowman DD; Reinemeyer CR
Parasit Vectors; 2021 May; 14(1):255. PubMed ID: 34001200
[TBL] [Abstract][Full Text] [Related]
14. Dose-titration studies of ivermectin against experimental Ancylostoma caninum and Uncinaria stenocephala infections.
Egerton JR; Eary CH; Suhayda D
Am J Vet Res; 1985 May; 46(5):1057-9. PubMed ID: 3839115
[TBL] [Abstract][Full Text] [Related]
15. An in vitro larval motility assay to determine anthelmintic sensitivity for human hookworm and Strongyloides species.
Kotze AC; Clifford S; O'Grady J; Behnke JM; McCarthy JS
Am J Trop Med Hyg; 2004 Nov; 71(5):608-16. PubMed ID: 15569793
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the efficacies of three heartworm preventives against experimentally induced infections with Ancylostoma caninum and Toxocara canis in pups.
Reinemeyer CR; Faulkner CT; Assadi-Rad AM; Burr JH; Patton S
J Am Vet Med Assoc; 1995 Jun; 206(11):1710-5. PubMed ID: 7782242
[TBL] [Abstract][Full Text] [Related]
17. Real-time PCR assays for monitoring benzimidazole resistance-associated mutations in Ancylostoma caninum.
Schwenkenbecher JM; Kaplan RM
Exp Parasitol; 2009 May; 122(1):6-10. PubMed ID: 19545525
[TBL] [Abstract][Full Text] [Related]
18. Utility of capsule endoscopy for evaluating anthelmintic efficacy in fully conscious dogs.
Lee AC; Epe C; Simpson KW; Bowman DD
Int J Parasitol; 2011 Nov; 41(13-14):1377-83. PubMed ID: 22075243
[TBL] [Abstract][Full Text] [Related]
19. Efficacy, safety and palatability of a new broad-spectrum anthelmintic formulation in dogs.
Schmid K; Rohdich N; Zschiesche E; Kok DJ; Allan MJ
Vet Rec; 2010 Oct; 167(17):647-51. PubMed ID: 21257464
[TBL] [Abstract][Full Text] [Related]
20. Reflecting on the past and fast forwarding to present day anthelmintic resistant Ancylostoma caninum-A critical issue we neglected to forecast.
Marsh AE; Lakritz J
Int J Parasitol Drugs Drug Resist; 2023 Aug; 22():36-43. PubMed ID: 37229949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
